ArticleCancer2022
Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapy.
Johanna E Poterala et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it